retatrutide
Retatrutide: Triple acting jab for type 2 diabetes lowers blood sugar and boosts weight loss, trial reports.
PubMed · Publication · 2026-06-09T00:00:00
Research Summary
Published in BMJ (Clinical research ed.).
Paper Metadata
Compound: retatrutide
Journal: BMJ (Clinical research ed.)
Source: PubMed
Type: Publication
Published: 2026 Jun 9
PubMed ID: 42264536
Authors
Lang K
Research Radar Analysis
AI analysis has not been generated for this paper yet.